Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2017-08-02 | 2018-02-21 | 18025 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2025-02-13 | 2025-04-10 | 250384 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Actual shortage | 2025-04-04 | 2025-05-08 | 254139 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-03-06 | 2020-03-26 | 107970 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2020-04-23 | 2020-05-08 | 113016 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2020-07-16 | 2020-11-07 | 120488 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-08-13 | 2020-11-07 | 122217 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-11-12 | 2021-01-28 | 128339 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2020-12-17 | 2021-01-21 | 130296 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2021-02-25 | 2021-05-06 | 134749 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2021-03-18 | 2021-05-06 | 135949 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2022-08-18 | 2023-04-28 | 167212 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2022-08-18 | 2022-12-15 | 167255 |
| TEVA-SPIRONOLACTONE | 25MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42604 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2023-06-08 | 2023-07-05 | 194071 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Resolved | 2023-06-16 | 2023-07-12 | 195225 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2022-12-01 | 2023-02-16 | 176842 |
| TEVA-SPIRONOLACTONE/HCTZ | 50MG 50MG | TABLET | Resolved | 2020-09-03 | 2021-02-05 | 123738 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2020-11-06 | 2021-02-05 | 128022 |
| TEVA-SPIRONOLACTONE/HCTZ | 25MG 25MG | TABLET | Resolved | 2017-08-02 | 2017-11-07 | 18021 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 100MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133880 |
| ACT CELECOXIB | 200MG | CAPSULE | Discontinued | 2021-02-12 | 2021-02-12 | 133874 |
| ACT CELECOXIB | 200MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123651 |
| ACT CELECOXIB | 100MG | CAPSULE | To be discontinued | 2020-09-03 | 2020-09-03 | 123648 |
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81418 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2019-04-11 | 2019-04-11 | 81381 |
| ACT DILTIAZEM CD | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142915 |
| ACT DILTIAZEM CD | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142918 |
| ACT DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2021-07-22 | 2021-07-22 | 142921 |
| TEVA-DILTIAZEM T | 300MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115126 |
| TEVA-DILTIAZEM T | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115117 |
| TEVA-DILTIAZEM T | 180MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115120 |
| TEVA-DILTIAZEM T | 240MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115123 |
| TEVA-DILTIAZEM T | 360MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-05-14 | 2020-05-14 | 115114 |
| ACT DONEPEZIL ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64872 |
| ACT DONEPEZIL ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-10-19 | 2018-10-19 | 64875 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 |